Surmodics

Surmodics is a provider of performance coating technologies for intravascular medical devices and of chemical and biological components for the healthcare industry. The company describes itself as a global leader in surface modification technologies for intravascular medical devices, with nearly 50 years of coatings experience and four feasibility and production centres. It serves customers globally, with operations in the United States, Ireland and Denmark.

Its technical work spans surface modification technologies, hydrophilic, hemocompatible, drug delivery and antimicrobial coatings, specialty polymers, analytical testing, contract manufacturing and in-vitro diagnostics technologies. Hydrophilic coating technology is designed to improve medical device performance across demanding and tortuous parts of the body; the hemocompatible and antimicrobial offerings are likewise directed at intravascular devices.

Beyond coatings, Surmodics provides analytical testing services to medical device manufacturers and contract manufacturing that supports customers from early feasibility through commercial manufacturing. Its stated focus is on helping customers improve device performance, accelerate development and reduce technical and regulatory risk.

Work at the company is grounded in deep technical expertise and manufacturing excellence, across industries including medical devices, intravascular medical devices, healthcare and in-vitro diagnostics. Further information is available at https://surmodics.com/.